InvestorsHub Logo
Followers 1371
Posts 72962
Boards Moderated 1
Alias Born 08/20/2007

Re: Mark post# 85964

Friday, 02/20/2015 10:38:22 AM

Friday, February 20, 2015 10:38:22 AM

Post# of 97237
ATNM, 3.50 added a few more, offering closed, link back for additional info.

Expects to begin a pivotal P3 trial for Iomab-B during 1H15 to prepare blood cancer (AML) pts for bone marrow transplant

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.